EVENTS:   The Roaring 2020s or a Rerun of the 1970s? - Edward Yardeni/Yardeni Research - 24 Mar 26   Best Equity Short Ideas Conference Call 13 - Thomas Chanos/Badger Consultants & Dr. Aaron Fletcher/Bios Research & Jonathan Telgener/Channel Dynamics & Ed Steele/Iron Blue Financials & John Zolidis/Quo Vadis Capital & Mark Hiley/The Analyst - 26 Mar 26     ROADSHOWS: Chinese Equity Ideas & Channel Checks Across 50 sub-sectors - Don Ma /Horizon Insights   •   London   23 - 27 Mar 26       Long Short European Equity Research - Harry Grist /The Analyst   •   New York   26 Mar 26       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   27 - 27 Mar 26      
Filters

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Bioceres Crop Solutions (BIOX)

Materials

MYST Advisors

Despite being the one of the fastest growing publicly traded Ag-tech companies (FY23 / FY24 Revenues & EBITDA expected to grow at least ~25%), BIOX is largely off the radar for most Investors. Its ability to reduce chemical applications, improve soil quality and conserve water puts the company at the forefront of environmental sustainability and positions it as the Ag leader in the transition to carbon neutrality and sustainability. TAM estimated to reach ~$100bn+ within the next 5 years. TP $27 (100%+ upside).

Edition: 146

- 14 October, 2022